Clinical Trial Update: A Prospective, Single-center, One-arm Clinical Study of Apatinib Combined With Chemotherapy for Pretreated Patients With Advanced Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 single-arm study evaluating apatinib plus chemotherapy in pretreated advanced small cell lung cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: The First Hospital of Jilin University | Conditions: Small-cell Lung Cancer | Phase 2 | Status: COMPLETED